Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening
Obstetrics & Gynecology Science · 2026-03-15 · 69 (2) · 85-93
DOI: 10.5468/ogs.26066 ↗At a glance
Leitlinie in Obstetrics & Gynecology Science, published on 2026-03-15. Written by Ju-Hyun Kim and 7 co-authors. Institution: Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. 23 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: National Cancer Center, Ministry of Health and Welfare.
Abstract (original language)
High-risk human papillomavirus (hrHPV) is an important cause of cervical cancer. hrHPV testing has emerged as an effective screening modality to address the limitations of cytology-based screening. However, in Korea, the absence of standardized clinical guidance has resulted in variability in practice. This consensus-based clinical practice guideline was developed by a multidisciplinary expert committee under the Korean Society of Gynecologic Oncology and includes specialists in gynecologic oncology, pathology, laboratory medicine, and public health. Relevant domestic and international evidence was systematically reviewed and perspectives from diverse clinical settings were incorporated through four public hearings. The final recommendations were established through expert consensus. These guidelines present four key recommendations. First, hrHPV testing may be considered for women aged ≥25 years, with a screening interval of 3 to
Subjects
Author keywords
Authors and institutions
- Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.
- Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Korea University School of Medicine, Ansan, Korea.
- Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University School of Medicine, Seoul, Korea.
- Department of Pathology, National Cancer Center, Goyang, Korea.
- Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Funding
- National Cancer Center
- Ministry of Health and Welfare
Cite
APA
Kim, J. H., Shim, S. H., Min, K. J., Lee, J. K., Yoo, C. W., Kwon, M. J., Lee, S. W., & Bae, J. (2026). Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening. Obstetrics & Gynecology Science, 69(2), 85-93. https://doi.org/10.5468/ogs.26066
Vancouver
Kim JH, Shim SH, Min KJ, Lee JK, Yoo CW, Kwon MJ, et al. Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening. Obstetrics & Gynecology Science. 2026;69(2):85-93. doi:10.5468/ogs.26066
BibTeX
@article{Kim2026,
author = {Kim, Ju-Hyun and Shim, Seung-Hyuk and Min, Kyung-Jin and Lee, Jae-Kwan and Yoo, Chong Woo and Kwon, Min-Jung and Lee, Shin-Wha and Bae, Jaeman},
title = {Consensus-based guideline of the Korean Society of Gynecologic Oncology for high-risk human papillomavirus testing in cervical cancer screening},
journal = {Obstetrics & Gynecology Science},
year = {2026},
volume = {69},
number = {2},
pages = {85--93},
doi = {10.5468/ogs.26066}
}
EUVIMED